Jiang, Lixin

High-quality health systems in the Sustainable Development Goals era: time for a revolution

Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., Doubova, S. V., et al. (2018) · The Lancet Global Health

Healthcare Quality and ManagementHealthcare Systems and Reforms

Cited by 4,057

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 2,479

Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)

Lu, J., Lu, Y., Wang, X., Li, X., Linderman, G. C., Wu, C., Cheng, X., Mu, L., Zhang, H., Liu, J., et al. (2017) · The Lancet

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 1,133

Perioperative Rosuvastatin in Cardiac Surgery

Zheng, Z., Jayaram, R., Jiang, L., Emberson, J., Zhao, Y., Li, Q., Du, J., Guarguagli, S., Hill, M., Chen, Z., et al. (2016) · New England Journal of Medicine

Cardiac, Anesthesia and Surgical OutcomesCardiac and Coronary Surgery Techniques

Cited by 322

Dietary Exposure to Aluminium and Health Risk Assessment in the Residents of Shenzhen, China

Yang, M., Jiang, L., Huang, H., Zeng, S., Qiu, F., Yu, M., Li, X., & Wei, S. (2014) · PLoS ONE

Aluminum toxicity and tolerance in plants and animalsHeavy Metal Exposure and Toxicity

Cited by 59

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial

Jabbour, E., Oehler, V. G., Koller, P. B., Jamy, O., Lomaia, E., Hunter, A. M., Uspenskaya, O., Samarina, S., Mukherjee, S., Cortes, J. E., et al. (2025) · JAMA Oncology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 33

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

on behalf of the SHARP Collaborative Group, Reith, C., Staplin, N., Herrington, W. G., Stevens, W., Emberson, J., Haynes, R., Mafham, M., Armitage, J., Cass, A., et al. (2017) · BMC Nephrology

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 16